News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Regulator To Fine Servier, Teva Pharmaceutical Industries Limited (TEVA) For Delaying Generic Drugs


6/20/2014 6:39:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BRUSSELS, June 19 (Reuters) - EU antitrust regulators are set to fine French drugmaker Servier, Israel's Teva and several of their peers next month for blocking cheaper generic medicine, two people with knowledge of the matter said on Thursday.

The sanctions will be the third action by the European Commission against so-called pay-for-delay deals in the pharmaceutical industry, where brand-name companies pay generics firms to refrain from putting rival medicines on the market.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Bloomberg


comments powered by Disqus
Reuters
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES